TrialFind
Saved trials
Back to results
Completed
Phase 1
Safety, Tolerability and Activity Study of Multiple Doses of ISIS-SGLT2Rx in Healthy Volunteers
NCT00836225
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Center for Human Drug Research
Leiden, Netherlands
View on ClinicalTrials.gov
Official details
Safety, Tolerability and Activity Study of Multiple Doses of ISIS-SGLT2Rx in Healthy Volunteers — TrialFind